Probiotics Boost Antimicrobial Peptides While Calming Inflammation Against Pseudomonas Gut Infections
Two probiotic strains enhanced beta-defensin 2 production while reducing inflammatory IL-8 in intestinal cells infected with Pseudomonas aeruginosa, through NOD1/Akt signaling.
Quick Facts
What This Study Found
Two probiotic strains (Lactobacillus rhamnosus GG and Bifidobacterium longum spp. infantis S12) produced a dual effect when administered to intestinal epithelial cells (SW480) before Pseudomonas aeruginosa infection:
hBD-2 was enhanced: probiotic pretreatment increased both mRNA expression and secreted protein of this antimicrobial peptide, strengthening the direct antimicrobial defense.
IL-8 was suppressed: the inflammatory chemokine IL-8 was reduced, meaning less inflammatory immune cell recruitment and less tissue damage.
The mechanism: probiotics enhanced P. aeruginosa-induced membranous NOD1 protein expression and Akt activation. When Akt or NOD1 were knocked down with siRNA, the probiotic effects on IL-8 and hBD-2 were both reversed. This confirms NOD1 and Akt are the regulatory nodes.
This reciprocal regulation (more antimicrobial defense, less inflammation) is the ideal immune response: kill the pathogen without destroying the tissue.
Key Numbers
2 probiotic strains; hBD-2 up, IL-8 down; NOD1 and Akt confirmed; siRNA knockdown reversed effects
How They Did This
In vitro cell culture study using SW480 intestinal epithelial cells. Cells were pretreated with probiotics, then infected with PAO1 Pseudomonas aeruginosa. IL-8 and hBD-2 measured at mRNA and protein levels. Akt and NOD1 signaling assessed. siRNA knockdown of Akt and NOD1 confirmed their roles.
Why This Research Matters
Pseudomonas aeruginosa can cause fatal sepsis, especially in young children. Antibiotics are the standard treatment but overuse drives resistance. Probiotics offer a complementary approach by boosting the body's own antimicrobial peptides while reducing the damaging inflammation that worsens disease. This dual action is more targeted than broad-spectrum antibiotics.
The Bigger Picture
Pseudomonas can cause fatal sepsis, especially in children. Probiotics offer a complementary approach to antibiotics by boosting natural defenses while reducing harmful inflammation. The specific mechanism through NOD1/Akt provides targets for more potent probiotic-based therapies.
What This Study Doesn't Tell Us
In vitro only, using a single intestinal cell line (SW480). Real intestinal tissue has multiple cell types, a mucus layer, and commensal bacteria that could modify the response. The probiotics were given before infection (pretreatment), not during; whether they work after infection starts is unknown. Only one Pseudomonas strain was tested.
Questions This Raises
- ?Would this protective effect work in living animals or humans?
- ?Are specific probiotic strains better at this dual defense-enhancement?
- ?Could probiotics be used preventively in ICU patients at risk for Pseudomonas infection?
Trust & Context
- Key Stat:
- Dual benefit probiotics simultaneously boosted antimicrobial defense (hBD-2) and calmed inflammation (IL-8) against Pseudomonas
- Evidence Grade:
- Preliminary evidence from a single cell line in vitro study. The dual mechanism is clearly demonstrated but lacks in vivo confirmation.
- Study Age:
- Published in 2020. Probiotic-AMP research continues to expand, with increasing focus on strain-specific effects.
- Original Title:
- Beneficial effect of probiotics on Pseudomonas aeruginosa-infected intestinal epithelial cells through inflammatory IL-8 and antimicrobial peptide human beta-defensin-2 modulation.
- Published In:
- Innate immunity, 26(7), 592-600 (2020)
- Authors:
- Huang, Fu-Chen, Lu, Yi-Ting, Liao, Yu-Hsuan
- Database ID:
- RPEP-04863
Evidence Hierarchy
Frequently Asked Questions
Can probiotics really help fight serious infections?
In this lab study, probiotics enhanced the gut's natural antimicrobial defenses while reducing harmful inflammation. Whether this translates to protection in actual patients requires clinical trials.
How do probiotics boost antimicrobial peptides?
The probiotics activated a specific immune sensor (NOD1) in gut cells through the Akt signaling pathway, which increased production of beta-defensin 2 — a natural antibiotic that kills harmful bacteria.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-04863APA
Huang, Fu-Chen; Lu, Yi-Ting; Liao, Yu-Hsuan. (2020). Beneficial effect of probiotics on Pseudomonas aeruginosa-infected intestinal epithelial cells through inflammatory IL-8 and antimicrobial peptide human beta-defensin-2 modulation.. Innate immunity, 26(7), 592-600. https://doi.org/10.1177/1753425920959410
MLA
Huang, Fu-Chen, et al. "Beneficial effect of probiotics on Pseudomonas aeruginosa-infected intestinal epithelial cells through inflammatory IL-8 and antimicrobial peptide human beta-defensin-2 modulation.." Innate immunity, 2020. https://doi.org/10.1177/1753425920959410
RethinkPeptides
RethinkPeptides Research Database. "Beneficial effect of probiotics on Pseudomonas aeruginosa-in..." RPEP-04863. Retrieved from https://rethinkpeptides.com/research/huang-2020-beneficial-effect-of-probiotics
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.